prior to the European Meeting on HIV & Hepatitis 2020




The European HIV Clinical Forum 2020: Optimizing Treatment will take place on 27 October in Paris, France. To keep the meeting accessible to all our participants, we have implemented a hybrid format that includes an opportunity to participate both onsite and virtually. Virtual participants can attend plenary sessions and roundtable discussions during the day of the meeting.


We are available to answer any questions or concerns that you may have about your participation at the European HIV Clinical Forum 2020: Optimizing TreatmentFor more information, please contact Mrs. Dagmar Jónasdóttir at


To stay updated on developments in relation to this forum meeting, make sure you are signed up for our newsletter.


The European HIV Clinical Forum 2020 provides an independent scientific program involving the world’s leading experts and is specifically designed for the European HIV healthcare professionals with the focus on optimizing treatment for their patients. The meeting is scheduled prior to the 18th European meeting on HIV & Hepatitis in Paris, France, which will allow healthcare professionals to combine both meetings in one trip thus limiting travel time and the number of days away from the clinic. 

This program will feature challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community in Europe. The program will end with a networking reception for community building; thus, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.



The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience and present the results from their ongoing and completed cohorts/ research programs.


Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.





Last year's edition of the European HIV Clinical Forum was organized on 5 November 2019, prior to the EACS - 17th European AIDS Conference. The forum attracted nearly 80 participants, from 23 European countries. The focus of last year's meeting was on important clinical developments and updates on ongoing and new trials in the field of optimizing treatment. The program featured several invited lectures, abstracts and clinical cases discussions. The day ended with a social get together over drinks, providing a unique opportunity to meet colleagues from different countries.

Feedback from the participants showed that the workshop was very well received. All off the respondents indicated that the lectures have increased their knowledge, 98% agreed that the program was beneficial for the clinical management of their patients, and 97% reported that they intend to incorporate the new information from the workshop into the care of their patients.




09:00 AM   

 Welcome, Introductions, and Goals:

 Guidance on Using Online Format and Online Needs Assessment

 Jonathan Schapiro, MD - Sheba Medical Center, Israel

SESSION 1 | State-of-the-Art Lectures: Update on Clinical Trials and Their Significance for Patient Management

Chairs: To be confirmed


09:20 AM 

Clinical update: Oral therapies for drug naïve and suppressed patients   

Gary Rubin, MD - University of Toronto, Canada


09:45 AM  

Clinical update: Injectable drug regimens

Charles Flexner, MD - Johns Hopkins University School of Medicine, USA


10:10 AM  

Clinical update: Highly treatment experienced patients

Michael Kozal, MD - Yale University, USA


10:35 AM  

Discussion and Q/A With Speakers From Session 1


10:55 AM  


 Coffee Break

SESSION 2 | Reduced Drug Regimens: Scientific Considerations

Chairs: To be confirmed


11:25 AM  

Virology: Implications for Resistance                          

Speaker: To be confirmed


11:25 AM  

Virology/Immunology: Implications for Reservoirs / Cure 

Mathias Lichterfeld, MD, PhD - Partners AIDS Research Center, USA


12:15 PM  

Pharmacology: Implications for poor adherence and sanctuary sites                                          Charles Flexner, MD - Johns Hopkins University School of Medicine, USA


12:40 PM  

Discussion and Q/A With Speakers From Session 2


13:15 PM  



SESSION 3 | Clinical Implementation of Long-Acting Therapies

Chairs: To be confirmed


14:15 PM  

Virological and Pharmacological monitoring: How and how often?                                              Andrea Calcagno, MD, DTM&H - University of Torino, Italy


14:40 PM  

Management of drug-drug interactions and poor adherence

Speaker: To be confirmed       


15:05 PM  

Financial considerations in oral versus parenteral HIV therapy    

Yazdan Yazdanpanah, MD, PhD - Hôpital Bichat-Claude Bernard, France


15:30 PM  

Discussion and Q/A With Speakers From Session 3


15:50 PM  


Coffee Break

SESSION 4 | Roundtable: Social / Logistical Barriers to Implementation of PrEP in Europe: What’s the Same, What’s Different?

Moderators: To be confirmed


16:20 PM  

Southern Europe: Italy/ Spain                                                                     

Pep Coll, MD - AIDS Research Institute-IrsiCaixa, Spain


16:35 PM  

Northern Europe: NL/ France/ Germany 

Speaker: To be confirmed


16:50 PM  

Eastern Europe: Poland/ Czech Rep.                                                                                           

David Jilich, MD - Hospital Na Bulovce, Czech Republic


17:05 PM  

Roundtable Discussion and Q/A With Speakers From Session 4


17:35 PM   

Summary and Closure of Program 

 Jonathan Schapiro, MD - Sheba Medical Center, Israel


Jonathan M. Schapiro, MD
National Hemophilia Center Sheba Medical Center

Charles Boucher, MD, PhD
Erasmus Medical Center
the Netherlands


Marcelin, MD

Hôpital Pitié-Salpétrière

Paris, France

Register now for the

European HIV Clinical Forum 2020

Paris, France | 27 October

Please note: this is a hybrid forum meeting. To access this workshop, you must register online!


The European HIV Clinical Forum 2020 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 6 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.



Registration is free of charge for all healthcare practitioners*. A registration fee applies to other individuals.

*Healthcare practitioners are defined as professionals that provide any type of health care service to patients living with HIV. Please contact the Conference Secretariat for more information at if you are not sure.



The application is open until 31 August 2020 at 23:59h CEST.
Virology Education is offering Scholarships to attend the 6th edition of the European HIV Clinical Forum 2020. Priority will be given to healthcare professionals from Europe who have actively participated in original research or scientific work that is being presented at the Meeting, are able to show how their patients / research will benefit from knowledge to be gained at this meeting, and who are willing and able to share the knowledge with larger community. (Please note: any applications from outside Europe will automatically be declined).

What the Scholarship covers:
  • Support for air travel of up to EUR 600

  • Hotel accommodation for 2 nights

a)    All arrangements will be made by Virology Education
b)    Applicants must attend the entire Conference.
c)    Applicants will be responsible for all other costs associated with Conference attendance. 
d)    Please see the Conference website for further details about the Conference. 

What is expected from you:

All scholarship awardees are required to attend the full meeting. Awardees must sign in at the beginning of each meeting day and sign off at the end of each day as requested by Conference Organizer. At the close of the Conference, awardees must have completed the daily and overall conference evaluations.

Recipient will provide a post-meeting feedback and summary about his/her conference experience within one month after the end of the conference. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the conference, Scholarship procedure and how they will implement the knowledge acquired at the meeting in their daily practice. The questionnaire will be sent to each recipient by email within one week after the conclusion of the conference.

  • Be proficient in English to interact with faculty and fellow attendees

  • Be a Healthcare Professional or professionally involved in the field of HIV.

  • Be resident of an European country.

  • Be able to show benefits to their patients / research from attending the meeting

  • Be willing and able to share information learned at the meeting with a larger community

  • Be eligible to obtain a visa for travel. Declare that she/he is able and willing to fund all other costs beyond the scholarship that are involved in attending the Conference, e.g. all other hotel, travel and subsistence expenses NOT covered by the Scholarship.

  • Declare to take out her/his own insurance policies (for travel, liability, illness and/or other necessary insurances in relation to her/his participation to the conference).

Conference organizer will automatically decline all Scholarship applications that do not conform to the eligibility terms.

Application procedure:
  • The scholarship applications must be submitted online through our Scholarship Application Portal. The applicant will be asked to submit a motivational letter (min. 100 words) describing how their patients / research will benefit from the knowledge gained at this meeting, and their knowledge dissemination strategy, a CV, and a letter of recommendation (optional).

The meeting code for the European HIV Clinical Forum is EURHCF2020.

  • All applications will be acknowledged upon receipt.

  • All applications will be reviewed by an independent Scholarship Review Committee.

  • All applicants will be notified about the status of their application no later than 45 days before the meeting date.

  • Successful applicants will be sent a scholarship agreement.

  • After receipt of signed Scholarship agreement, successful applicants will receive instructions for travel arrangements.

Please submit your application through the Scholarship Application Portal on the Conference website.  

We humbly request your support in encouraging healthcare professionals to apply by forwarding this information to your colleagues.

Selection Criteria:

  • Professional background

  • Country of residence

  • Recommendation by your supervisor

  • Demonstrable benefits to patients / research / community by the knowledge to be gained at this meeting

  • Strategy of knowledge dissemination



  • Incomplete applications will not be considered. Conference Organizer cannot be held responsible for any incorrect information that is submitted through the Scholarship application portal.

  • All travel arrangements will be made by Conference Organizer in collaboration with their preferred business travel partner. Conference Organizer cannot reimburse any travel costs made by participants themselves.

  • Retrospective applications will not be considered.

  • Scholarship recipients must attend the entire conference.

  • Scholarship recipients are committed to attend the meeting in person. If they fail to do so, they will be charged the full amount of the travel and accommodation costs incurred and will be excluded from applications for future Scholarships of Conference Organizer.

  • Scholarships are non-transferrable.

  • Conference Organizer cannot guarantee awarding the Scholarship to prospective scholarship recipients until the confirmation of available funds. In the event that sufficient funding for the Scholarship is not available, Conference Organizer will not be liable for any expenses or damages incurred by the prospective scholarship recipient with regards to the Scholarship application and/or preparation for the meeting.

  • Applications will be considered until the exhaustion of funds.

  • Scholarship recipients will be responsible for all other costs associated with conference attendance.

  • Conference Organizer will not be liable for any injury, death, damage, loss, delay, cost, expense, or inconvenience, causes of action claims and suits for property damage, theft of property or personal injury (including death) arising in connection with the Scholarship and participation in the Conference.

  • Conference Organizer reserves the right to make the final decision regarding all applications, which cannot be disputed.

Please submit your application through the Scholarship Application Portal.


The European HIV Clinical Forum 2020 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Logo BHIVA-RGB.jpg
International Association of Providers of AIDS Care (IAPAC)

We trust that the following information (in alphabetical order) will assist you in organizing your registration and stay to the European HIV Clinical Forum 2020: Optimizing Treatment.


Information on accommodation will follow shortly.


Make sure to pick up your badge at the registration desk. All participants are requested to wear the badge at all times during the forum meeting to ensure admission to the venue.


Certificate of Attendance

A certificate of attendance will be sent by e-mail after the forum meeting in the following week.



This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.

Internet Access

Free Wi-Fi will be available in the meeting room. Access codes to the free Wi-Fi will be shared on the first day of this forum meeting.


The official language of this meeting is English.

Liability and Insurance

By registering for this forum meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.

Meeting Materials

Meeting materials can be obtained upon registration at the registration desk at the venue starting at 08:00h on the meeting date.


Meeting Venue

The meeting will be held at the Pullman Paris Centre - Bercy Hotel, located in the center of Paris.

Pullman Paris Centre Bercy

1 Rue de Libourne

75012 Paris 




Telephone: +33 1 44 67 34 00

Location: Google Maps

Payment and Procedure of Online Registration

Registration is free of charge for all healthcare practitioners. You will get a confirmation of the registration within 1-5 business days. If you did not receive a confirmation, please contact the Organizing Secretariat by e-mail:


Photographs, Audio, and Video Recording

Photographs, as well as audio and video recordings, are not permitted at the official forum meeting sessions. Only the official medical writer, appointed by the organization, may make recordings. All presentations will be posted on the forum website as soon as possible after the meeting is finished, provided the speaker has given permission to do so.




For any inquiries or questions, please contact Virology Education at or call +31 (0)30 230 7146. You can also contact us by filling out the contact form.

Inna Laven

Team Leader

Dagmar Jónasdóttir

Project Coordinator

Contact form